SPTLC1基因变异与青少年肌萎缩侧索硬化症相关
这项多中心家族遗传学研究对青少年ALS患者进行三人全外显子测序,发现SPTLC1基因的新发变异(p.Ala20Ser、p.Ser331Tyr、p.Leu39del)与青少年ALS相关。研究提示SPTLC1变异可导致青少年ALS表型,建议对青少年ALS患者筛查该基因。
要点
- SPTLC1基因新发变异与青少年ALS及生长迟缓相关
- p.Ala20Ser见于2例,p.Ser331Tyr和p.Leu39del各1例
- 青少年ALS患者应考虑SPTLC1基因筛查
核心结论
- SPTLC1基因变异与青少年ALS相关,扩展了该基因的表型谱。
研究设计与样本
- 多中心家族遗传学研究,对3例青少年ALS患者及父母行三人全外显子测序,另筛查63例青少年ALS和6258例成人ALS患者的SPTLC1基因。
主要发现
- 3例无家族史的青少年ALS伴生长迟缓患者携带SPTLC1新发变异(p.Ala20Ser 2例,p.Ser331Tyr 1例)。
- 另1例青少年ALS患者检出p.Leu39del变异,但父母DNA不可用。
关键数值与推荐
- SPTLC1变异此前已知与常染色体显性遗传性感觉自主神经病1A型相关,通过破坏鞘脂合成通路中的酶复合物致病。
临床怎么用
- 对表现为青少年ALS的患者,建议进行SPTLC1基因变异筛查。
局限性
- 部分患者父母DNA不可用,无法确认新发状态。
- 样本量较小,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Juvenile amyotrophic lateral sclerosis (ALS) is a rare form of ALS characterized by age of symptom onset less than 25 years and a variable presentation. OBJECTIVE: To identify the genetic variants associated with juvenile ALS. DESIGN, SETTING, AND PARTICIPANTS: In this multicenter family-based genetic study, trio whole-exome sequencing was performed to identify the disease-associated gene in a case series of unrelated patients diagnosed with juvenile ALS and severe growth retardation. The patients and their family members were enrolled at academic hospitals and a government research facility between March 1, 2016, and March 13, 2020, and were observed until October 1, 2020. Whole-exome sequencing was also performed in a series of patients with juvenile ALS. A total of 66 patients with juvenile ALS and 6258 adult patients with ALS participated in the study. Patients were selected for the study based on their diagnosis, and all eligible participants were enrolled in the study. None of the participants had a family history of neurological disorders, suggesting de novo variants as the underlying genetic mechanism. MAIN OUTCOMES AND MEASURES: De novo variants present only in the index case and not in unaffected family members. RESULTS: Trio whole-exome sequencing was performed in 3 patients diagnosed with juvenile ALS and their parents. An additional 63 patients with juvenile ALS and 6258 adult patients with ALS were subsequently screened for variants in the SPTLC1 gene. De novo variants in SPTLC1 (p.Ala20Ser in 2 patients and p.Ser331Tyr in 1 patient) were identified in 3 unrelated patients diagnosed with juvenile ALS and failure to thrive. A fourth variant (p.Leu39del) was identified in a patient with juvenile ALS where parental DNA was unavailable. Variants in this gene have been previously shown to be associated with autosomal-dominant hereditary sensory autonomic neuropathy, type 1A, by disrupting an essential enzyme complex in the sphingolipid synthesis pathway. CONCLUSIONS AND RELEVANCE: These data broaden the phenotype associated with SPTLC1 and suggest that patients presenting with juvenile ALS should be screened for variants in this gene.
引用
- Johnson JO, Chia R, Miller DE, et al. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. JAMA Neurol. 2021. PMID: 34459874. doi:10.1001/jamaneurol.2021.2598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。